Dr. Grant received his PhD in chromatographic and mass spectrometric technologies from Swansea University in 1995. He continued his scientific training in various industrial settings which have included: Senior scientist at GSK, Principal scientist at Cohesive Technologies, Technical Director at Eli Lilly and Director of Mass Spectrometry at Esoterix Endocrinology. Dr. Grant has pioneered the use of direct injection technologies, chromatographic systems multiplexing, multidimensional LC-LC, utility of automation and new analytical platforms for application in bioanalytical and clinical applications. His research goals are focused upon improvements in speed, sensitivity and quality of LC-MS/MS analytical systems and assays.